Back

Assessing dual pathology in aortic stenosis: Likelihood scores for transthyretin amyloid cardiomyopathy in patients of different aortic stenosis flow groups undergoing TAVI.

1 September 2025 (12:30 - 13:15)
Organised by: Logo
Congress Presentation Part of: New perspectives in cardiology (4) - TAVI and aortic stenosis Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Stephanie Schwarting

Ludwig Maximilians University, Munich (Germany)

6 More presentations in this session

Presentation thumbnail
Presentation thumbnail
Doctor S. Kikuchi (Strasbourg, FR)
Abstract Slides Video
Presentation thumbnail
Doctor A. Apostolos (London, GB)
Abstract Slides Video
Presentation thumbnail
Doctor B. Soh (Galway, IE)
Abstract Slides Video
Presentation thumbnail
Mr S. Narui (Tokyo, JP)
Abstract Slides Video

Access the full session

Session thumbnail
New perspectives in cardiology (4) - TAVI and aortic stenosis

The Event

Event poster

ESC Congress 2025

1 September 2025 12:30 CET
You may be interested in
thumbnail
Congress Presentation
External validation of the RAISE score for the diagnosis of transthyretin-related cardiac amyloidosis in patients with severe aortic stenosis undergoing transcatheter aortic valve replacement
thumbnail
Congress Presentation
Prevalence of amyloidosis among patients with mild to severe aortic stenosis. Validation of screening parameters.
thumbnail
Congress Presentation
Multimodality imaging and genetic assessment in the diagnosis of amyloid cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources